Group: Structural Biology Group TorVergata - with tag drug_design [14 articles] Export

Recent papers posted by members of the Structural Biology Group TorVergata group with tag drug_design

	Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research [My Copy] Journal of Pharmaceutical and Biomedical Analysis, Vol. 22, No. 5. (June 2000), pp. 717-727. by S. Agatonovic-Kustrin posted to neural_networks modeling drug_design by A_Coletta_Thesis to the group Structural Biology Group TorVergata on 2009-10-06 12:02:06 as
	Artificial neural networks for computer-based molecular design [My Copy] Progress in Biophysics and Molecular Biology, Vol. 70, No. 3. (November 1998), pp. 175-222. by G. Schneider posted to neural_networks modeling drug_design by A_Coletta_Thesis to the group Structural Biology Group TorVergata on 2009-10-06 11:59:25 as along with 1 person LamBras
	Drug Design Presentation [My Copy] by Ester Papa posted to drug_design by oteri to the group Structural Biology Group TorVergata on 2009-04-03 17:21:23 as
	Novel Indazole Non-Nucleoside Reverse Transcriptase Inhibitors Using Molecular Hybridization Based on Crystallographic Overlays† [My Copy] Journal of Medicinal Chemistry, Vol. 0, No. 0. (0000) by Lyn H. Jones, Gill Allan, Oscar Barba, et al.Catherine Burt, Romuald Corbau, Thomas Dupont, Thorsten Knöchel, Steve Irving, Donald S. Middleton, Charles E. Mowbray, Manos Perros, Heather Ringrose, Nigel A. Swain, Robert Webster, Mike Westby, Chris Phillips posted to docking drug_design by oteri to the group Structural Biology Group TorVergata on 2009-01-30 10:44:48 as
	Discovery of (2S,4R)-1-(2-Aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic Acid Hydrochloride (GAP-134)13, an Orally Active Small Molecule Gap-Junction Modifier for the Treatment of Atrial Fibrillation [My Copy] Journal of Medicinal Chemistry, Vol. 0, No. 0. (0000) by John A. Butera, Bjarne D. Larsen, James K. Hennan, et al.Edward Kerns, Li Di, Asaf Alimardanov, Robert E. Swillo, Gwen A. Morgan, Kun Liu, Qiang Wang, Eric I. Rossman, Rayomand Unwalla, Leonard Mcdonald, Christine Huselton, Jørgen S. Petersen posted to docking drug_design by oteri to the group Structural Biology Group TorVergata on 2009-01-30 10:41:06 as
	Derivatives of 5-Nitro-furan-2-carboxylic Acid Carbamoylmethyl Ester Inhibit RNase H Activity Associated with HIV-1 Reverse Transcriptase [My Copy] Journal of Medicinal Chemistry, Vol. 0, No. 0. (0000) by Hideyoshi Fuji, Emiko Urano, Yuko Futahashi, et al.Makiko Hamatake, Junko Tatsumi, Tyuji Hoshino, Yuko Morikawa, Naoki Yamamoto, Jun Komano posted to docking drug_design by oteri to the group Structural Biology Group TorVergata on 2009-01-30 10:39:35 as
	QXP: powerful, rapid computer algorithms for structure-based drug design. [My Copy] J Comput Aided Mol Des, Vol. 11, No. 4. (July 1997), pp. 333-344. by C. McMartin, R. S. Bohacek posted to docking drug_design by oteri to the group Structural Biology Group TorVergata on 2009-01-27 14:25:21 as along with 2 people flbarroso BragilMassoud
	Design, Synthesis, and Structure−Activity Relationship Studies of 3,4,6-Triphenylpyran-2-ones as Selective Cyclooxygenase-2 Inhibitors [My Copy] Journal of Medicinal Chemistry, Vol. 47, No. 16. (1 July 2004), pp. 3972-3990. by Praveen P. N. Rao, Md Uddin, Edward E. Knaus posted to drug_design by oteri to the group Structural Biology Group TorVergata on 2009-01-27 11:10:20 as
	Docking Studies on a New Human Immodeficiency Virus Integrase−Mg−DNA Complex: Phenyl Ring Exploration and Synthesis of 1H-Benzylindole Derivatives through Fluorine Substitutions [My Copy] Journal of Medicinal Chemistry, Vol. 52, No. 2. (22 January 2009), pp. 569-573. by Stefania Ferro, Laura De Luca, Maria L. Barreca, et al.Nunzio Iraci, Sara De Grazia, Frauke Christ, Myriam Witvrouw, Zeger Debyser, Alba Chimirri posted to docking drug_design by oteri to the group Structural Biology Group TorVergata on 2009-01-26 11:06:23 as
	Discovery of Potent Thermolysin Inhibitors Using Structure Based Virtual Screening and Binding Assays [My Copy] Journal of Medicinal Chemistry, Vol. 52, No. 1. (January 2009), pp. 48-61. by Mahmud T. Khan, Ole-Martin Fuskevåg, Ingebrigt Sylte posted to drug_design by oteri to the group Structural Biology Group TorVergata on 2009-01-26 10:50:52 as along with 1 group LOX-1 Receptor
	Efficient docking of peptides to proteins without prior knowledge of the binding site. [My Copy] Protein science : a publication of the Protein Society. , Vol. 11, No. 7. (July 2002), pp. 1729-1737. by Csaba Hetényi, David van der Spoel posted to docking drug_design by oteri to the group Structural Biology Group TorVergata on 2008-12-27 13:24:04 as along with 3 people and 1 group npt11tpn yongzhao rguenther TSRI_MGL
	Protein-Ligand Interactions: From Molecular Recognition to Drug Design [My Copy] posted to docking drug_design by oteri to the group Structural Biology Group TorVergata on 2008-12-10 13:52:10 as
	Calculation of protein-ligand binding affinities. [My Copy] Annual review of biophysics and biomolecular structure, Vol. 36 (2007), pp. 21-42. by Michael K. Gilson, Huan-Xiang X. Zhou posted to docking drug_design by oteri to the group Structural Biology Group TorVergata on 2008-12-10 13:47:26 as along with 15 people and 2 groups mijogiffin flbarroso GermanErlenkamp onufriev arlam jmccammon bmduggan dimka neils hmk ashaytan ras cchang boris_aguilar qaiser_fatmi Chang group McCammon
	Targeting the X-linked inhibitor of apoptosis protein through 4-substituted azabicyclo[5.3.0]alkane smac mimetics. Structure, activity, and recognition principles. [My Copy] Journal of molecular biology, Vol. 384, No. 3. (19 December 2008), pp. 673-689. by E. Mastrangelo, F. Cossu, M. Milani, et al.G. Sorrentino, D. Lecis, D. Delia, L. Manzoni, C. Drago, P. Seneci, C. Scolastico, V. Rizzo, M. Bolognesi posted to drug_design by oteri to the group Structural Biology Group TorVergata on 2008-12-10 13:39:10 as along with 1 person higueruelo

Note: You may cite this page as: http://www.citeulike.org/group/7862/tag/drug_design

nanotech	58
pka	40
review	38
ccne	36
docking	33
protein_ligand	30
cancer	27
structure	17
eg5	15
kinesin	15
ligand	12
molecular_motors	12
protein_structure	11
sccne	11
biomembranes	10
ultrasound	10
monastrol	9
protein-protein	9
protein_dynamics	9
bioinformatics	8
imaging	8
protein-ligand_interactions	8
selective_binding	8
cytoskeleton	7
hiv	7
targets	7
free_energy	6
informatics	6
inhibitor_design	6
kinases	6
md_simulation	6
nucleic_acids	6
open_source	6
solvation	6
data	5
ontology	5
alternatives	4
cheminformatics	4
chemogenomics	4
computational_chemistry	4
dna	4
electrostatics	4
emulsions	4
ftsz	4
hivpr	4
kubinyi	4
modeling	4
neural_networks	4
pharma_issue	4
tubulin	4
virology	4
wet_lab	4
adaptation	3
bioinf_methods	3
cell_cycle_inhibitors	3
decision_trees	3
drug_discovery	3
high_throughput_screening	3
insilico_design	3
kinetics	3
misc	3
mitosis	3
mm-pbsa	3
protein_sequence	3
validation	3
3d	2
apbs	2
computer_based	2
data_integration	2
database	2
drug_development	2
gb	2
higher_order_chromatin	2
hiv_rt	2
life_science	2
molecular_dynamics	2
molecular_simulation	2
mts	2
nachr	2
personalized_medicine	2
protein	2
protein-membrane_interactions	2
protein_mechanics	2
refinement	2
resistance	2
rna_polymerase	2
semantics	2
astex	1
binding_mode	1
collaboration	1
erk2	1
game_theory	1
lead	1
mutations	1
optimization	1
pca	1
protein-prediction	1
protein_protein_interactions	1
sterols	1
surface	1

Group: Structural Biology Group TorVergata

Group: Structural Biology Group TorVergata - with tag drug_design [14 articles] Export

Related Tags